إعلان
إعلان
CAMP
CAMP4 Therapeutics Corporation Common Stock
6.19
USDبرعاية
-0.01
-0.23%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
6.21
+0.02
+0.39%
تقارير أرباح CAMP
النسبة الإيجابية المفاجئة
CAMP تفوق 2 من 5 آخر التقديرات.
40%
التقرير التالي
بيانات التقرير القادم
١١ مايو ٢٠٢٦
Estimate for Q1 26 (Revenue/ EPS)
$306.00K
/-$0.26
التغير الضمني من Q3 25 (Revenue/ EPS)
-61.51%
/-52.73%
التغير الضمني من Q1 25 (Revenue/ EPS)
-64.34%
/-58.06%
CAMP4 Therapeutics Corporation Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, CAMP reported earnings of -0.55 USD per share (EPS) for Q3 25, missing the estimate of -0.48 USD, resulting in a -12.73% surprise. Revenue reached 795.00 ألف, compared to an expected 530.40 ألف, with a 49.89% difference. The market reacted with a -4.49% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 المحللين forecast an EPS of -0.26 USD, with revenue projected to reach 306.00 ألف USD, implying an نقصان of -52.73% EPS, and نقصان of -61.51% in Revenue from the last quarter.
الأسئلة الشائعة
What were CAMP4 Therapeutics Corporation Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CAMP4 Therapeutics Corporation Common Stock reported EPS of -$0.55, missing estimates by -12.73%, and revenue of $795.00K, 49.89% above expectations.
How did the market react to CAMP4 Therapeutics Corporation Common Stock's Q3 2025 earnings?
The stock price moved down -4.49%, changed from $4.45 before the earnings release to $4.25 the day after.
When is CAMP4 Therapeutics Corporation Common Stock expected to report next?
The next earning report is scheduled for ١١ مايو ٢٠٢٦.
What are the forecasts for CAMP4 Therapeutics Corporation Common Stock's next earnings report?
Based on 5
المحللين, CAMP4 Therapeutics Corporation Common Stock is expected to report EPS of -$0.26 and revenue of $306.00K for Q1 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان